Literature DB >> 33643175

Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report.

Si-Ying Song1,2,3, Zhong-Ao Wang1,2,3, Yu-Chuan Ding3,4, Xun-Ming Ji1,2,3, Ran Meng1,2,3.   

Abstract

This study reported two cases of intracranial thrombotic events of aplastic anemia (AA) under therapy with cyclosporine-A (CsA) and reviewed both drug-induced cerebral venous thrombosis (CVT) and CsA-related thrombotic events systematically. We searched PubMed Central (PMC) and EMBASE up to Sep 2019 for publications on drug-induced CVT and Cs-A-induced thrombotic events. Medical subject headings and Emtree headings were used with the following keywords: "cyclosporine-A" and "cerebral venous thrombosis OR cerebral vein thrombosis" and "stroke OR Brain Ischemia OR Brain Infarction OR cerebral infarction OR intracerebral hemorrhage OR intracranial hemorrhage." We found that CsA might be a significant risk factor in inducing not only CVT but also cerebral arterial thrombosis in patients with AA.
Copyright © 2021 Song, Wang, Ding, Ji and Meng.

Entities:  

Keywords:  case report; cerebral arterial infarction; cerebral venous sinus thrombosis; cyclosporine-A; systematic review

Year:  2021        PMID: 33643175      PMCID: PMC7906016          DOI: 10.3389/fneur.2020.563037

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  111 in total

1.  Danazol-induced life-threatening cerebral venous thrombosis in a patient with aplastic anemia.

Authors:  G Sudheer Kumar; V R Roopesh Kumar; M S Gopalakrishnan; C V Shankar Ganesh; M S Venkatesh
Journal:  Neurol India       Date:  2011 Sep-Oct       Impact factor: 2.117

2.  Cerebral venous sinus thrombosis in a woman using the etonogestrel-ethinyl estradiol vaginal contraceptive ring: a case report.

Authors:  Caitlin Dunne; Doug Malyuk; Tabassum Firoz
Journal:  J Obstet Gynaecol Can       Date:  2010-03

3.  Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin "flushes".

Authors:  Majed A Refaai; Theodore E Warkentin; Michael Axelson; Karen Matevosyan; Ravindra Sarode
Journal:  Thromb Haemost       Date:  2007-11       Impact factor: 5.249

4.  Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia.

Authors:  P Ho; S Khan; D Crompton; L Hayes
Journal:  Intern Med J       Date:  2015-06       Impact factor: 2.048

5.  De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination.

Authors:  Robert M Langer; Charles T Van Buren; Stephen M Katz; Barry D Kahan
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

Review 6.  The combined vaginal contraceptive ring, nuvaring, and cerebral venous sinus thrombosis: a case report and review of the literature.

Authors:  Christian Kolacki; Vito Rocco
Journal:  J Emerg Med       Date:  2011-09-25       Impact factor: 1.484

Review 7.  The etiologies of new cases of cerebral venous sinus thrombosis reported in the past year.

Authors:  Ran Meng; Xunming Ji; Xiaoying Wang; Yuchuan Ding
Journal:  Intractable Rare Dis Res       Date:  2012-02

8.  Dural sinus and cerebral venous thrombosis. Incidence in young women receiving oral contraceptives.

Authors:  D S Buchanan; J H Brazinsky
Journal:  Arch Neurol       Date:  1970-05

9.  A case with cerebral thrombosis receiving tamoxifen treatment.

Authors:  G Akdal; B Dönmez; H Cakmakçi; G G Yener
Journal:  Eur J Neurol       Date:  2001-11       Impact factor: 6.089

10.  Cerebral venous thrombosis after high dose steroid in multiple sclerosis: a case report.

Authors:  S Gazioglu; D Solmaz; C Boz
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

View more
  1 in total

1.  Nonthrombotic internal jugular venous stenosis may facilitate cerebral venous thrombosis.

Authors:  Xiaoqin Wu; Jingyuan Ya; Da Zhou; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  CNS Neurosci Ther       Date:  2021-08-16       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.